An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin.
An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin.
复制标题
DOI:
10.1016/j.jpha.2021.02.004
复制
发表时间:
2021-12
影响因子:
8.8
通讯作者:
Zhou QT
中科院分区:
文献类型:
--
作者:
Yuan H;Yu S;Chai G;Liu J;Zhou QT
Inhaled antibiotics such as colistin and ciprofloxacin are increasingly used to treat bacterial lung infections in cystic fibrosis patients. In this study, we established and validated a new HPLC-MS/MS method that could simultaneously detect drug concentrations of ciprofloxacin, colistin and ivacaftor in rat plasma, human epithelial cell lysate, cell culture medium, and drug transport media. An aliquot of 200 μL drug-containing rat plasma or cell culture medium was treated with 600 μL of extraction solution (acetonitrile containing 0.1% formic acid and 0.2% trifluoroacetic acid (TFA)). The addition of 0.2% TFA helped to break the drug-protein bonds. Moreover, the addition of 0.1% formic acid to the transport medium and cell lysate samples could significantly improve the response and reproducibility. After vortexing and centrifuging, the sample components were analyzed by HPLC-MS/MS. The multiple reaction monitoring mode was used to detect the following transitions: 585.5–101.1 (colistin A), 578.5–101.1 (colistin B), 393.2–337.2 (ivacaftor), 332.2–314.2 (ciprofloxacin), 602.3–101.1 (polymyxin B1 as internal standard (IS)) and 595.4–101.1 (polymyxin B2 as IS). The running time of a single sample was only 6 min, making this a time-efficient method. Linear correlations were found for colistin A at 0.029–5.82 μg/mL, colistin B at 0.016–3.14 μg/mL, ivacaftor at 0.05–10.0 μg/mL, and ciprofloxacin at 0.043–8.58 μg/mL. Accuracy, precision, and stability of the method were within the acceptable range. This method would be highly useful for research on cytotoxicity, animal pharmacokinetics, and in vitro drug delivery. The method is highly useful for analysis on cytotoxicity, pharmacokinetics, and in vitro drug delivery for cystic fibrosis. The method is the first validated method for analysis of colistin, ivacaftor and ciprofloxacin simultaneously. The method could be employed in analysis of plasma, epithelial cell, cell culture medium, and drug transport media. Trifluoroformic acid was used as a drug-protein bond cleavage, and formic acid was added to increase the response of drugs. The method could detect the three model drugs within 6 min.
登录
查看更多内容
DOI:
10.1016/j.jpba.2008.12.016
发表时间:
2009-04-05
影响因子:
3.4
作者:
Jansson, Britt;Karvanen, Matti;Friberg, Lena E.
通讯作者:
Friberg, Lena E.
影响因子:
5.8
作者:
Chai, Guihong;Park, Heejun;Zhou, Qi (Tony)
通讯作者:
Zhou, Qi (Tony)
DOI:
10.1016/j.jcf.2014.02.004
发表时间:
2014-09
期刊:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
影响因子:
--
作者:
Reznikov LR;Abou Alaiwa MH;Dohrn CL;Gansemer ND;Diekema DJ;Stoltz DA;Welsh MJ
通讯作者:
Welsh MJ
影响因子:
3.1
作者:
Caro, Ester;Marce, Rosa M.;Borrull, Francesc
通讯作者:
Borrull, Francesc
影响因子:
4.9
作者:
Buyck, Julien M.;Tulkens, Paul M.;Van Bambeke, Franoise
通讯作者:
Van Bambeke, Franoise